| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.26 | 0.4 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |